9ZDL | pdb_00009zdl

A6-A11 diselenide glargine insulin

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-13C HSQC	0.3 mM Se-glargine insulin	100% D2O/10% d4-acetic acid	0.5 mM	2.1	1 atm	298	Bruker AVANCE NEO 700
2	2D 1H-15N HSQC	0.3 mM Se-glargine insulin	90% H2O/10% D2O/10% d4-acetic acid	0.5 mM	2.1	1 atm	298	Bruker AVANCE NEO 700
3	2D 1H-1H NOESY	0.3 mM Se-glargine insulin	90% H2O/10% D2O/10% d4-acetic acid	0.5 mM	2.1	1 atm	298	Bruker AVANCE NEO 700
4	2D 1H-1H NOESY	0.3 mM Se-glargine insulin	100% D2O/10% d4-acetic acid	0.5 mM	2.1	1 atm	298	Bruker AVANCE NEO 700
5	2D 1H-1H TOCSY	0.3 mM Se-glargine insulin	90% H2O/10% D2O/10% d4-acetic acid	0.5 mM	2.1	1 atm	298	Bruker AVANCE NEO 700
6	2D 1H-1H TOCSY	0.3 mM Se-glargine insulin	100% D2O/10% d4-acetic acid	0.5 mM	2.1	1 atm	298	Bruker AVANCE NEO 700

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	700

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	TopSpin	4.05	Bruker Biospin
2	chemical shift assignment	Sparky		Goddard
3	peak picking	Sparky		Goddard
4	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore